Filter By Industry
Filter By Tag

Newsroom

NAPSRx Press releases

21 - 30 of 357 Press Releases

Apr 27, 2015
Eli Lilly’s breakthrough cancer treatment CYRAMZA® (ramucirumab) has received another approval from the U.S Food and Drug Administration (FDA) making this the fourth approved indication for the treatment.

Apr 24, 2015
The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and granted priority review for Abbvie’s all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with...

Apr 21, 2015
Pfizer has received Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for  XALKORI® (crizotinib) to potentially treat patients with ROS1-positive non-small cell lung cancer (NSCLC).

Apr 16, 2015
The U.S. Food and Drug Administration (FDA) has approved Amgen’s Corlanor® (ivabradine) to treat chronic heart failure.

Apr 13, 2015
Horizon Pharma plc has announced that ACTIMMUNE® has been granted Fast Track designation from the U.S. Food and Drug Administration (FDA), to treat Friedreich's ataxia (FA), a degenerative neuro-muscular disorder.

Apr 07, 2015
Bristol-Myers Squibb (BMS) will get exclusive access to uniQure’s gene technology platform based on a strategic collaboration between both companies to identify multiple targets in cardiovascular diseases.

Apr 01, 2015
ProAir® RespiClick is the first Breath-Actuated Dry-Powder Short-Acting Beta-Agonist (SABA) Inhaler to be approved by the FDA.

Mar 31, 2015
Jadenu, a new formulation of Exjade (deferasirox) is a simplified daily treatment, administered to patients with chronic iron overload.

Mar 27, 2015
The U.S. Food and Drug Administration (FDA) has officially greenlighted Regeneron’s EYLEA® (aflibercept) Injection to treat Diabetic Retinopathy in Patients with Diabetic Macular Edema (DME) which marks the fourth approved indication for the drug in...

Mar 25, 2015
AstraZeneca will enter into a five-year research collaboration with the Harvard Stem Cell Institute (HSCI)  in order to acclimatize a technique for the creation of human beta cells from stem cells for use in screens of AstraZeneca’s compound...


Page: Prev 1 2 3 4 5 Next
NAPSRx RSS Feed